This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (117)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Does Vancomycin Resistance Make a Difference?

Valentina Stosor, MD; Lance R. Peterson, MD; Michael Postelnick, RPh; Gary A. Noskin, MD

Arch Intern Med. 1998;158:522-527.

Background  Enterococcus faecium has received increased attention, primarily due to the emergence of vancomycin resistance. The purpose of this investigation was to study the epidemiological characteristics of vancomycin-resistant E faecium (VRE) bacteremia and to determine the clinical impact of vancomycin resistance on the outcome of patients with this infection.

Methods  We retrospectively analyzed the clinical features and outcome of 53 patients with E faecium bacteremia.

Results  From January 1992 until December 1995, there were 32 episodes of bacteremia caused by vancomycin-susceptible E faecium (VSE) and 21 caused by VRE. An intra-abdominal site was the most common source of bacteremia in both groups. All of the VRE and 78% of VSE bacteremia cases were nosocomially acquired. Previous administration of vancomycin was associated with VRE bacteremia (P<.001), as were indwelling bladder catheters (P=.01). Fifty-nine percent of the patients with VSE bacteremia survived vs 24% with VRE (P=.009), despite similar severity-of-illness scores. In 62% of the patients with VRE sepsis, death was related to the bacteremia (P=.01). Patients infected with VRE had longer hospitalizations than those with VSE (34.8 vs 16.7 days, respectively) (P=.004), were more likely to be on the medical service (P=.03), and on the average, had hospitalization costs of more than $27000 per episode than did patients with VSE bloodstream infection ($83897 vs $56707, respectively) (P=.04).

Conclusions  Vancomycin-resistant E faecium bacteremia is a complication of prolonged hospitalization in debilitated patients. Vancomycin resistance has a negative impact on survival in patients with E faecium bacteremia and leads to higher health care costs.

From the Division of Infectious Diseases, Department of Medicine, and the Clinical Microbiology Section, Department of Pathology, Northwestern University Medical School (Drs Stosor, Peterson, and Noskin), and the Department of Pharmacy, Northwestern Memorial Hospital (Mr Postelnick), Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Defining an antimicrobial monitoring service
Baker and Sehdev
Am J Health Syst Pharm 2008;65:2095-2099.
FULL TEXT  

Peptide Nucleic Acid Fluorescent In Situ Hybridization for Hospital-Acquired Enterococcal Bacteremia: Delivering Earlier Effective Antimicrobial Therapy
Forrest et al.
Antimicrob. Agents Chemother. 2008;52:3558-3563.
ABSTRACT | FULL TEXT  

Preoperative Evaluation of Patients With History of Allergy to Penicillin: Comparison of 2 Models of Practice
Frigas et al.
Mayo Clin Proc. 2008;83:651-657.
ABSTRACT | FULL TEXT  

Evaluation of a Novel Chromogenic Agar Medium for Isolation and Differentiation of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Isolates
Ledeboer et al.
J. Clin. Microbiol. 2007;45:1556-1560.
ABSTRACT | FULL TEXT  

Emerging Incidence of Enterococcus faecium among Hospital Isolates (1993 to 2002)
Treitman et al.
J. Clin. Microbiol. 2005;43:462-463.
ABSTRACT | FULL TEXT  

Clinical and Economic Analysis of Methicillin-Susceptible and -Resistant Staphylococcus aureus Infections
Kopp et al.
The Annals of Pharmacotherapy 2004;38:1377-1382.
ABSTRACT | FULL TEXT  

Role of Environmental Contamination as a Risk Factor for Acquisition of Vancomycin-Resistant Enterococci in Patients Treated in a Medical Intensive Care Unit
Martinez et al.
Arch Intern Med 2003;163:1905-1912.
ABSTRACT | FULL TEXT  

Health and Economic Outcomes of Vancomycin-Resistant Enterococci
Carmeli et al.
Arch Intern Med 2002;162:2223-2228.
ABSTRACT | FULL TEXT  

Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci
Harbarth et al.
Antimicrob. Agents Chemother. 2002;46:1619-1628.
FULL TEXT  

Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon
Osmon
JBJS 2001;83:1891-1901.
FULL TEXT  

Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study
Vergis et al.
ANN INTERN MED 2001;135:484-492.
ABSTRACT | FULL TEXT  

Yield of Vancomycin-Resistant Enterococci and Multidrug-Resistant Enterobacteriaceae from Stools Submitted for Clostridium difficile Testing Compared to Results from a Focused Surveillance Program
Hacek et al.
J. Clin. Microbiol. 2001;39:1152-1154.
ABSTRACT | FULL TEXT  

Relationships between Enterococcal Virulence and Antimicrobial Resistance
Mundy et al.
Clin. Microbiol. Rev. 2000;13:513-522.
ABSTRACT | FULL TEXT  

Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium in a Large Urban Hospital over a 5-Year Period
Bischoff et al.
J. Clin. Microbiol. 1999;37:3912-3916.
ABSTRACT | FULL TEXT  

The Association Between Antecedent Vancomycin Treatment and Hospital-Acquired Vancomycin-Resistant Enterococci: A Meta-analysis
Carmeli et al.
Arch Intern Med 1999;159:2461-2468.
ABSTRACT | FULL TEXT  

Prediction of Poorer Prognosis by Infection With Antibiotic-Resistant Gram-positive Cocci Than by Infection With Antibiotic-Sensitive Strains
Gleason et al.
Arch Surg 1999;134:1033-1040.
ABSTRACT | FULL TEXT